Streeterville Capital Amends China Pharma Holdings Stake
Ticker: CPHI · Form: SC 13G/A · Filed: Jan 12, 2024 · CIK: 1106644
| Field | Detail |
|---|---|
| Company | China Pharma Holdings, Inc. (CPHI) |
| Form Type | SC 13G/A |
| Filed Date | Jan 12, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: beneficial-ownership, institutional-holding, amendment
TL;DR
**Streeterville Capital just updated their stake in China Pharma Holdings, keep an eye on institutional ownership.**
AI Summary
Streeterville Capital LLC, a Chicago-based investment firm, filed an amended Schedule 13G/A on January 12, 2024, indicating a change in their beneficial ownership of China Pharma Holdings, Inc. common stock. This filing, an amendment to a previous disclosure, shows that Streeterville Capital LLC continues to hold a significant stake in the pharmaceutical company. For investors, this matters because large institutional holdings can influence stock stability and signal confidence (or lack thereof) in the company's future.
Why It Matters
This filing updates the public on Streeterville Capital LLC's ownership in China Pharma Holdings, Inc., which can impact investor sentiment and potentially the stock's liquidity.
Risk Assessment
Risk Level: low — This is a routine amendment to a beneficial ownership filing and does not inherently signal high risk.
Analyst Insight
Investors should monitor future 13G/A filings from Streeterville Capital LLC to track any significant increases or decreases in their ownership, as this could signal their evolving confidence in China Pharma Holdings, Inc.
Key Players & Entities
- Streeterville Capital LLC (company) — filing an amendment to their beneficial ownership of China Pharma Holdings, Inc.
- China Pharma Holdings, Inc. (company) — the subject company whose common stock is being reported on
- John M. Fife (person) — listed as a group member associated with the filing
- Streeterville Management LLC (company) — listed as a group member associated with the filing
- 03 Life Sciences (company) — an organization name associated with China Pharma Holdings, Inc.
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change in beneficial ownership.
Who is the subject company of this filing?
The subject company is China Pharma Holdings, Inc., with a Central Index Key (CIK) of 0001106644.
Who filed this SC 13G/A?
This SC 13G/A was filed by Streeterville Capital LLC, located at 303 E Wacker Drive, Suite 1040, Chicago, IL 60601.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the common stock, $0.001 par value, of China Pharma Holdings, Inc. is 16941T203.
When was this amendment filed and what date does it cover?
This amendment was filed on January 12, 2024, and the 'Date of Event Which Requires Filing of this Statement' is Calendar Year 2024.
Filing Stats: 1,591 words · 6 min read · ~5 pages · Grade level 8.8 · Accepted 2024-01-12 14:42:50
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securiti
Filing Documents
- doc1.htm (SC 13G/A) — 95KB
- 0001567619-24-000010.txt ( ) — 97KB
From the Filing
SC 13G/A 1 doc1.htm NONE Schedule 13G UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* China Pharma Holdings, Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 16941T203 (CUSIP Number) Calendar Year 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 16941T203 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Streeterville Capital LLC 85-2954598 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Utah NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 3,291,872 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 3,291,872 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,291,872 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO FOOTNOTES * Reporting Person Streeterville Capital LLC ("Streeterville") has rights under a Convertible Promissory Note to own an aggregate number of shares of the Issuer's ordinary shares which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's ordinary shares beneficially owned by Streeterville as of the date of this filing was 3,291,872 shares, which is 9.99% of the 32,951,673 shares outstanding on November 10, 2023, (as reported in the Issuer's 10-Q filed on November 13, 2023). CUSIP No. 16941T203 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Streeterville Management LLC 85-3223919 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Utah NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 3,291,872 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 3,291,872 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,291,872 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO FOOTNOTES * Reporting person Streeterville Management LLC is the Manager of reporting person Streeterville. Streeterville has rights under a Convertible Promissory Note to own an aggregate number of shares of the Issuer's ordinary shares which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's ordinary shares beneficially owned by Streeterville as of the date of this filing was 3,291,872 shares, which is 9.99% of the 32,951,673 shares outstanding on November 10, 2023, (as reported in the Issuer's 10-Q filed on November 13, 2023). CUSIP No. 16941T203 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) John M. Fife 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 3,291,872 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 3,291,872 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,291,872 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN FOOTNOTES * John M. Fife is the sole member of Streeterville Management LLC, which is the Manager of reporting person Streeterville. St